Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421173 | SCV000519612 | benign | not specified | 2016-09-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001514190 | SCV001721974 | benign | Brugada syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328939 | SCV002627749 | benign | Cardiovascular phenotype | 2018-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000421173 | SCV003928302 | benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004708838 | SCV005238237 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000421173 | SCV001919490 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000421173 | SCV001955376 | benign | not specified | no assertion criteria provided | clinical testing |